The objective of the Training Program in Immunology at Sloan-Kettering Institution is to provide junior postdoctoral fellows a solid foundation in the field of Immunology and to direct their interests towards important aspects of the immune system and its response to infectious agents, self antigens, and cancer. Four postdoctoral positions are requested for this competitive renewal, which is unchanged from the past grant period. The duration of training will be 2 years. The Training Program provides trainees with the intensive training, resources and experience necessary for them to develop successful careers in academia, government, and industry as independent researchers and leaders. Areas of research training cover lymphocyte development and biology, signaling, innate immunity, infectious immunity, transplantation immunity and cancer immunology. The objectives of the Training Program are achieved by providing a structured environment with intensive involvement in immunology research, further strengthened by attendance at weekly seminars and research-in-progress meetings, monthly research colloquia and translational research seminars and an annual retreat. Trainees are also expected to participate in advanced courses covering contemporary topics of immunology and workshops on bioinformatics and grant writing skills. The major part of the training comes from the research experience under the tutelage of preceptors who are engaged in cutting-edge immunology research, with bearing on lymphocyte biology, cell signaling and transcription, innate immunity, infectious diseases, autoimmune diseases, transplantation and cancer. Trainees can also take advantage of the many interdisciplinary collaborations between members of the Immunology Training Program and respected outside scientists, both locally and nationally.

Public Health Relevance

Among the major health problems afflicting the US populace today are infectious diseases, autoimmune diseases, and cancer. The training program we propose will train a new cohort of postdoctoral scientists in immunology, with an emphasis on learning how the immune system interacts with tumor cells and how to mobilize the immune system to attack tumors. There have been recent remarkable successes in clinical trials in modulating the immune system to effectively treat cancer in humans, and our goal is to train new scientists to continue and expand this approach to cancer therapy.

Agency
National Institute of Health (NIH)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009149-38
Application #
8717588
Study Section
Subcommittee B - Comprehensiveness (NCI)
Program Officer
Lim, Susan E
Project Start
Project End
Budget Start
Budget End
Support Year
38
Fiscal Year
2014
Total Cost
Indirect Cost
City
New York
State
NY
Country
United States
Zip Code
10065
Heaton, Brook E; Barkan, Daniel; Bongiorno, Paola et al. (2014) Deficiency of double-strand DNA break repair does not impair Mycobacterium tuberculosis virulence in multiple animal models of infection. Infect Immun 82:3177-85
Fay, Allison; Glickman, Michael S (2014) An essential nonredundant role for mycobacterial DnaK in native protein folding. PLoS Genet 10:e1004516
Matthews, Allysia J; Husain, Solomon; Chaudhuri, Jayanta (2014) Binding of AID to DNA does not correlate with mutator activity. J Immunol 193:252-7
Matthews, Allysia J; Zheng, Simin; DiMenna, Lauren J et al. (2014) Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair. Adv Immunol 122:1-57
Harris, Kendra K; Fay, Allison; Yan, Han-Guang et al. (2014) Novel imidazoline antimicrobial scaffold that inhibits DNA replication with activity against mycobacteria and drug resistant Gram-positive cocci. ACS Chem Biol 9:2572-83
Beaulieu, Aimee M; Zawislak, Carolyn L; Nakayama, Toshinori et al. (2014) The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat Immunol 15:546-53
Bos, Paula D; Plitas, George; Rudra, Dipayan et al. (2013) Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J Exp Med 210:2435-66
Ouyang, Weiming; Oh, Soyoung A; Ma, Qian et al. (2013) TGF-* cytokine signaling promotes CD8+ T cell development and low-affinity CD4+ T cell homeostasis by regulation of interleukin-7 receptor * expression. Immunity 39:335-46
Zawislak, Carolyn L; Beaulieu, Aimee M; Loeb, Gabriel B et al. (2013) Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155. Proc Natl Acad Sci U S A 110:6967-72
Schaer, David A; Murphy, Judith T; Wolchok, Jedd D (2012) Modulation of GITR for cancer immunotherapy. Curr Opin Immunol 24:217-24

Showing the most recent 10 out of 29 publications